Skip to main content
logo
Hanmi Pharm. Co., Ltd. (KRX:128940)
South Korea flag South Korea · Delayed Price · Currency is KRW
482,500
-26,500 (-5.21%)
Last updated: Aug 31, 2026, 1:54 PM KST

Hanmi Pharm. Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
217,045169,554121,315146,23182,79267,025
Depreciation & Amortization
99,66098,80997,33198,45496,84289,086
Loss (Gain) From Sale of Assets
-8.34-101.2-27.74-1,769-451.651,062
Asset Writedown & Restructuring Costs
3,0883,0132,4889,1533,794535.2
Loss (Gain) From Sale of Investments
-4,945-4,76287.92-2,630-47.09-
Loss (Gain) on Equity Investments
19.227.459.2-1,2588,5374.02
Provision & Write-off of Bad Debts
6,8803,346-593.891,277723.065,118
Other Operating Activities
61,67953,27463,14024,47643,76692,609
Change in Accounts Receivable
-25,441-87,255-61,052-3,21737,286-76,613
Change in Inventory
-100,065-37,0351,928-16,903-14,36518,916
Change in Accounts Payable
11,44312,458-10,4385,574-2,7369,794
Change in Other Net Operating Assets
3,541-38,238-20,701-42,852-93,870-5,613
Operating Cash Flow
272,895173,072193,487216,538162,269201,923
Operating Cash Flow Growth
80.34%-10.55%-10.64%33.44%-19.64%33.25%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-56,518-43,025-39,261-27,352-30,378-19,949
Sale of Property, Plant & Equipment
279.85462.7250.862,6001,39786.37
Sale (Purchase) of Intangibles
-33,468-32,997-22,768-16,156-20,273-14,199
Investment in Securities
35,953-53,626103,827-138,865-118,609-6,953
Other Investing Activities
-4,133-3,974-3,650-3,699-13,545-2,375
Investing Cash Flow
-96,475-159,45524,851-183,472-181,408-43,389

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
-142,400431,830134,650230,000102,700
Long-Term Debt Issued
-38,00049,000-7,00030,000
Total Debt Issued
250,000180,400480,830134,650237,000132,700
Short-Term Debt Repaid
--193,500-472,330-202,650-116,800-198,800
Long-Term Debt Repaid
--53,234-86,431-37,720-147,240-36,476
Total Debt Repaid
-275,535-246,734-558,761-240,370-264,040-235,276
Net Debt Issued (Repaid)
-25,535-66,334-77,931-105,720-27,040-102,576
Issuance of Common Stock
00----
Repurchase of Common Stock
---3,280-3,071-3,834-4,874
Dividends Paid
-32,197-30,855-12,555-17,996-5,992-5,881
Other Financing Activities
----0--
Financing Cash Flow
-57,732-97,190-93,767-126,787-36,867-113,331

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
11,812-431.3212,7271,373-5,89017,864
Net Cash Flow
130,500-84,004137,297-92,348-61,89663,067

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
216,378130,048154,226189,186131,890181,974
Free Cash Flow Growth
97.75%-15.68%-18.48%43.44%-27.52%65.85%
Free Cash Flow Margin
13.07%8.40%10.31%12.69%9.90%15.12%
Free Cash Flow Per Share
17047.1610248.7712162.1314906.6710382.3714307.73
Levered Free Cash Flow
48,7122,284132,235156,408193,044159,618
Unlevered Free Cash Flow
57,68012,901147,468174,226207,199169,979

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
13,46417,06024,74727,84619,49818,315
Cash Income Tax Paid
61,22246,29022,12031,43229,6326,599
Change in Working Capital
-110,523-150,069-90,263-57,397-73,686-53,516